Stock listing

NASDAQ:GELS Gelteq Limited Stock

Home listing (NASDAQ) of Gelteq Limited

Follow Gelteq Limited into a list and get an email when it puts out news.

Share price · NASDAQ:GELS

$0.448 USD +0.018 (+4.1%)

Close on Oct 20, 2026

Past 3 months -25.1% · daily closes, Jul 6, 2026 – Oct 20, 2026, adjusted for splits
Day range
$0.430 – $0.449 USDOct 20, 2026
Volume
23,637 sharesOct 20, 2026
Market cap
$4.80M USDAt the close on Oct 20, 2026 · price × 10.71M shares outstanding
Gelteq Limited logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:GELS · Home$0.448 USD+0.018 (+4.1%)23,637$0.430$0.449$0.430$0.430Close on Oct 20, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NASDAQ:GELS · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.448+0.018+4.1%$0.430$0.449$0.43023,637
$0.430-0.016-3.5%$0.452$0.465$0.430190,125
$0.446+0.015+3.6%$0.450$0.490$0.43140,140
$0.431-0.020-4.4%$0.446$0.450$0.43017,094
$0.450-0.030-6.2%$0.473$0.478$0.45038,212
$0.480-0.010-2.1%$0.490$0.528$0.48061,724
$0.490-0.031-5.9%$0.498$0.516$0.47451,969
$0.521-0.028-5.0%$0.560$0.560$0.52154,582
$0.549-0.011-2.0%$0.549$0.553$0.54018,618
$0.560-0.020-3.4%$0.571$0.580$0.55089,386
$0.580+0.036+6.6%$0.524$0.580$0.52472,500
$0.544+0.023+4.4%$0.538$0.571$0.52037,300
$0.521-0.022-4.1%$0.527$0.542$0.52070,200
$0.543+0.013+2.5%$0.532$0.554$0.500200,300
$0.530-0.001-0.2%$0.533$0.559$0.52038,700
$0.531-0.016-2.9%$0.540$0.546$0.52255,600
$0.547+0.001+0.2%$0.552$0.560$0.52796,000
$0.546-0.004-0.7%$0.546$0.547$0.52579,300
$0.550-0.051-8.5%$0.520$0.585$0.520284,800
$0.601-0.009-1.5%$0.542$0.637$0.526524,200
$0.610+0.039+6.8%$0.559$0.946$0.43633,661,000
$0.571+0.009+1.6%$0.558$0.601$0.55831,600
$0.562-0.018-3.1%$0.580$0.585$0.55575,600
$0.5800.0000.0%$0.609$0.609$0.56663,300
$0.580-0.036-5.8%$0.600$0.632$0.58085,300
$0.616-0.064-9.4%$0.668$0.668$0.58097,000
$0.680-0.020-2.9%$0.697$0.710$0.65071,700
$0.700-0.087-11.1%$0.780$0.780$0.70092,300
$0.787-0.063-7.4%$0.784$0.870$0.640343,600
$0.850+0.174+25.7%$0.660$0.850$0.636700,200
$0.676-0.224-24.9%$0.834$0.834$0.632536,200
$0.900+0.007+0.8%$0.805$0.900$0.7711,462,800
$0.893+0.193+27.6%$0.991$1.120$0.74970,094,700
$0.700+0.168+31.6%$0.569$0.826$0.53271,637,600
$0.532-0.014-2.6%$0.540$0.551$0.53016,700
$0.546-0.010-1.8%$0.549$0.549$0.5424,300
$0.556-0.014-2.5%$0.570$0.575$0.53011,500
$0.570-0.010-1.7%$0.565$0.580$0.55116,600
$0.580+0.032+5.8%$0.587$0.587$0.5605,000
$0.548+0.016+3.0%$0.526$0.589$0.52637,100
$0.532-0.031-5.5%$0.539$0.562$0.52017,800
$0.563+0.005+0.9%$0.589$0.589$0.53721,000
$0.558+0.002+0.4%$0.560$0.580$0.53029,600
$0.556+0.024+4.5%$0.530$0.590$0.53011,200
$0.532-0.032-5.7%$0.530$0.585$0.53027,600
$0.564-0.016-2.8%$0.602$0.617$0.56035,000
$0.580-0.001-0.2%$0.612$0.630$0.58026,600
$0.581+0.010+1.8%$0.591$0.612$0.57011,100
$0.571+0.000+0.1%$0.569$0.605$0.55120,400
$0.571-0.014-2.4%$0.576$0.601$0.57012,976
$0.585+0.027+4.8%$0.570$0.605$0.55833,847
$0.558-0.016-2.8%$0.583$0.583$0.54611,400
$0.574+0.010+1.8%$0.580$0.640$0.57055,800
$0.564+0.030+5.6%$0.540$0.585$0.54053,800
$0.534-0.006-1.1%$0.560$0.606$0.53456,700
$0.540+0.020+3.8%$0.520$0.569$0.48680,200
$0.520-0.031-5.6%$0.553$0.638$0.52025,400
$0.551-0.025-4.3%$0.580$0.620$0.55177,500
$0.576-0.011-1.9%$0.596$0.597$0.55067,900
$0.587-0.074-11.2%$0.630$0.645$0.570107,200
$0.661-0.040-5.7%$0.695$0.700$0.66048,600
$0.701-0.042-5.7%$0.745$0.779$0.697119,900
$0.743+0.064+9.4%$0.650$0.879$0.638502,100
$0.679+0.069+11.3%$0.626$0.689$0.610250,400
$0.610+0.020+3.4%$0.590$0.625$0.578197,100
$0.590-0.016-2.6%$0.600$0.606$0.576104,900
Ticker
NASDAQ:GELS
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs

Jun 17, 2026

Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications

Jun 12, 2026

Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion

Jun 4, 2026

Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway

May 20, 2026

Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth

May 12, 2026

Gelteq and Healthy Extracts to Expand Gel-Based Nutrition Technologies with New Strategic Manufacturing & Commercial Partnership

Feb 11, 2026

Gelteq Announces Positive Preclinical Results Showing Increased Medicinal Cannabinoid Absorption Using Its Oral Gel Delivery Platform

Jan 13, 2026

Gelteq Furthers Asia Presence Through Partnership with Hong Kong Flag Football Program

Dec 16, 2025

Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into China

Dec 9, 2025

Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform

Dec 5, 2025

All Gelteq Limited news

Decks

Gelteq Limited on 6ix

Sector
Health care
Industry
Biotechnology
News releases
14 in the last 12 months · 31 in all · newest Jun 17, 2026 · oldest 2024
Decks
1 deck · latest Dec 9, 2025

Where Gelteq Limited is listed

ListingExchangeCountryCurrency
NASDAQ:GELS · Home listing · This pageNASDAQUnited StatesUSD
BOATS:GELSBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Gelteq Limited.